204 related articles for article (PubMed ID: 10557041)
1. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
Pullen J; Shuster JJ; Link M; Borowitz M; Amylon M; Carroll AJ; Land V; Look AT; McIntyre B; Camitta B
Leukemia; 1999 Nov; 13(11):1696-707. PubMed ID: 10557041
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
3. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.
Sutcliffe MJ; Shuster JJ; Sather HN; Camitta BM; Pullen J; Schultz KR; Borowitz MJ; Gaynon PS; Carroll AJ; Heerema NA
Leukemia; 2005 May; 19(5):734-40. PubMed ID: 15789069
[TBL] [Abstract][Full Text] [Related]
4. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
[TBL] [Abstract][Full Text] [Related]
5. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
6. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
[TBL] [Abstract][Full Text] [Related]
7. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
9. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM
Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645
[No Abstract] [Full Text] [Related]
10. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study.
Borowitz MJ; Shuster J; Carroll AJ; Nash M; Look AT; Camitta B; Mahoney D; Lauer SJ; Pullen DJ
Blood; 1997 Jun; 89(11):3960-6. PubMed ID: 9166833
[TBL] [Abstract][Full Text] [Related]
11. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
13. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Smith M; Arthur D; Camitta B; Carroll AJ; Crist W; Gaynon P; Gelber R; Heerema N; Korn EL; Link M; Murphy S; Pui CH; Pullen J; Reamon G; Sallan SE; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
J Clin Oncol; 1996 Jan; 14(1):18-24. PubMed ID: 8558195
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children.
Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM
J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia.
Pui CH; Hancock ML; Head DR; Rivera GK; Look AT; Sandlund JT; Behm FG
Blood; 1993 Aug; 82(3):889-94. PubMed ID: 7687897
[TBL] [Abstract][Full Text] [Related]
16. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
17. Childhood T-lineage acute lymphoblastic leukemia: management and outcome at a tertiary care center in North India.
Arya LS; Padmanjali KS; Sazawal S; Saxena R; Bhargava M; Kulkarni KP; Adde M; Magrath I
Indian Pediatr; 2011 Oct; 48(10):785-90. PubMed ID: 21555798
[TBL] [Abstract][Full Text] [Related]
18. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia.
Nakamura A; Tsurusawa M; Kato A; Taga T; Hatae Y; Miyake M; Mimaya J; Onodera N; Watanabe A; Watanabe T; Kanegane H; Matsushita T; Iwai A; Hyakuna N; Gushi K; Kawakami T; Sekine I; Izichi O; Asami K; Kikuta A; Tanaka A; Fujimoto T;
Leuk Lymphoma; 2001 Jul; 42(3):393-8. PubMed ID: 11699404
[TBL] [Abstract][Full Text] [Related]
20. Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.
Laver JH; Barredo JC; Amylon M; Schwenn M; Kurtzberg J; Camitta BM; Pullen J; Link MP; Borowitz M; Ravindranath Y; Murphy SB; Shuster J
Leukemia; 2000 Mar; 14(3):369-73. PubMed ID: 10720128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
